"We are fully committed to bringing this breakthrough drug to patients as quickly as possible while backing everything we do ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

Investment analysts at Rodman & Renshaw began coverage on shares of MIRA Pharmaceuticals (NASDAQ:MIRA – Get Free Report) in a research report issued to clients and investors on Monday ...

Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic pain MIAMI, FL / ACCESSWIRE / September 27, 2024 / MIRA Pharmaceuticals ...

Additional information about MIRA Pharmaceuticals is available at: www.mirapharmaceuticals.com. This press release and the statements of MIRA Pharmaceuticals' (or the "Company") management related ...

Breakthrough Therapies And Novel Treatments - This Biopharma Is Out To Change The Game Why Mira Shares Are Trading Higher Today MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) shares are trading higher ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...